ReviewAnatomy & cell biology2025
Ultrasound observational anatomical guideline for retrobulbar hyaluronidase injection.
Review in Anatomy & cell biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The growing use of injectable cosmetic fillers has been accompanied by an increase in reports of acute vision loss, typically caused by inadvertent intravascular injection and subsequent embolization of the ophthalmic artery, resulting in ocular ischemia. Effective management of this complication remains challenging, as clear clinical guidelines for retrobulbar hyaluronidase injection are lacking. This ultrasound-based observational anatomical guideline provides practical recommendations for retrobulbar administration of hyaluronidase. Real-time ultrasonography allows for direct visualisation of orbital anatomy, enabling the injector to identify the optic nerve sheath complex and surrounding vascular structures. The central retinal artery's entry point into the optic canal is a key anatomical landmark for directing treatment. Based on ultrasound observations, the inferolateral quadrant of the orbit is identified as the safest and most accessible entry site, reducing the risk of damage to extraocular muscles, cranial nerves, and major vessels. The use of ultrasonography enhances both precision and safety, supporting timely and effective management of filler-related ocular complications. Ultrasound observation further confirms that the inferolateral orbital approach offers the most reliable and safe access for retrobulbar hyaluronidase injection. The superior orbital rim and close proximity of the globe restrict needle trajectory from above, increasing the risk of ocular injury. In contrast, the inferior approach provides a wider anatomical corridor, reduces the likelihood of direct contact with the eyeball, and allows safer navigation around critical neurovascular structures. Incorporating real-time ultrasound enhances precision, making the inferior approach the preferred route for managing filler-related ocular complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.